索引超出了数组界限。
[1] NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends
in hypertension prevalence and progress in treatment and control
from 1990 to 2019: a pooled analysis of 1201 populationrepresentative
studies with 104 million participants[J]. Lancet,
2021, 398(10304):957-980.
[2] Oparil S, Acelajado MC, Bakris GL, et al. Hypertension [J]. Nat
Rev Dis Primers, 2018, 4:18014.
[3] Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy
number in the human genome[J]. Nature, 2006, 444(7118):444-
454.
[4] Macé A, Kutalik Z, Valsesia A. Copy number variation [J].
Methods Mol Biol, 2018, 1793:231-258.
[5] Huber MJ, Chen QH, Shan ZY. The orexin system and
hypertension[J]. Cell Mol Neurobiol, 2018, 38(2):385-391.
[6] Charchar FJ, Kaiser M, Bingham AJ, et al. Whole genome survey
of copy number variation in the spontaneously hypertensive rat:
relationship to quantitative trait loci, gene expression, and blood
pressure[J]. Hypertension, 2010, 55(5):1231-1238.
[7] Jankowich M, Choudhary G. Endothelin-1 levels and
cardiovascular events[J]. Trends Cardiovasc Med, 2020, 30(1):1-8.
[8] Barton M, Yanagisawa M. Endothelin: 30 years from discovery
to therapy[J]. Hypertension, 2019, 74(6):1232-1265.
[9] Sun YV, Peyser PA, Kardia SLR. A common copy number
variation on chromosome 6 association with the gene expression
level of endothelin 1 in transformed B lymphocytes from three
racial groups[J]. Circ Cardiovasc Genet, 2009, 2(5):483-488.
[10] Seravalle G, Grassi G. Obesity and hypertension[J]. Pharmacol
Res, 2017, 122:1-7.
[11] Phillips M, Babu JR, Wang X, et al. DNA copy number and
structural variation (CNV) contributions to adult and childhood
obesity[J]. Biochem Soc Trans, 2020, 48(4):1819-1828.
[12] Zhao W, Wineinger NE, Tiwari HK, et al. Copy number
variations associated with obesity-related traits in African
Americans: a joint analysis between GENOA and HyperGEN[J].
Obesity (Silver Spring), 2012, 20(12):2431-2437.
[13] Yildiz M, Oktay AA, Stewart MH, et al. Left ventricular
hypertrophy and hypertension[J]. Prog Cardiovasc Dis, 2020,
63(1):10-21.
[14] Boonpeng H, Yusoff K. The utility of copy number variation
(CNV) in studies of hypertension-related left ventricular
hypertrophy (LVH): rationale, potential and challenges[J]. Mol
Cytogenet, 2013, 6(1):8.
[15] Zou WW, Slone J, Cao YX, et al. Mitochondria and their role in
human reproduction[J]. DNA Cell Biol, 2020, 39(8):1370-1378.
[16] 付浩, 孙圣凯, 陈孝储, 等. 高血压大鼠线粒体DNA拷贝数与端
粒长度的相关性研究[J]. 中国医药导报, 2016, 13(31):33-36.
[17] Wilson PWF, D'Agostino RB, Parise H, et al. Metabolic
syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus[J]. Circulation, 2005, 112(20):3066-3072.
[18] Fazzini F, Lamina C, Raftopoulou A, et al. Association of
mitochondrial DNA copy number with metabolic syndrome and
type 2 diabetes in 14 176 individuals[J]. J Intern Med, 2021,
290(1):190-202.
[19] 中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期
高血压疾病诊治指南(2020)[J]. 中华妇产科杂志, 2020,
55(4):227-238.
[20] Wu GP, Li R, Tong C, et al. Non-invasive prenatal testing reveals
copy number variations related to pregnancy complications[J].
Mol Cytogenet, 2019, 12:38.
[21] Mulvihill E, Ardoin S, Thompson SD, et al. Elevated serum
complement levels and higher gene copy number of complement
C4B are associated with hypertension and effective response to
statin therapy in childhood-onset systemic lupus erythematosus
(SLE)[J]. Lupus Sci Med, 2019, 6(1):e000333.
[22] Wineinger NE, Pajewski NM, Kennedy RE, et al.
Characterization of autosomal copy-number variation in African
Americans: the HyperGEN Study[J]. Eur J Hum Genet, 2011,
19(12):1271-1275.
[23] Crawford K, Bracher-Smith M, Owen D, et al. Medical
consequences of pathogenic CNVs in adults: analysis of the UK
Biobank[J]. J Med Genet, 2019, 56(3):131-138.
[24] Marques FZ, Prestes PR, Pinheiro LB, et al. Measurement of
absolute copy number variation reveals association with essential
hypertension[J]. BMC Med Genomics, 2014, 7:44.
[25] 张旭昌, 刘雪燕, 陈怀生, 等. 基于全基因组重测序技术探索
原发性高血压易感基因[J]. 中华高血压杂志, 2017, 25(8):737-
744.
[26] Chen X, Li X, Wang P, et al. Novel association strategy with
copy number variation for identifying new risk Loci of human
diseases[J]. PLoS One, 2010, 5(8):e12185.